Poor Prostate Cancer Knowledge Leads to Conflicted Decisions

Share this content:
Findings seen in economically disadvantaged men with newly diagnosed prostate cancer.
Findings seen in economically disadvantaged men with newly diagnosed prostate cancer.

For economically disadvantaged men with newly diagnosed prostate cancer, poor knowledge about prostate cancer is associated with increased decisional conflict and lower perceived effectiveness of decision-making, according to a study published in Cancer.

Alan L. Kaplan, M.D., from the University of California in Los Angeles, and colleagues surveyed 70 men (mean age, 63 years; 70 percent reported income of less than $30,000) with newly diagnosed localized prostate cancer enrolled in a trial to test a novel shared decision-making tool. The Decisional Conflict Scale, Uncertainty Subscale, and Perceived Effectiveness Subscale were assessed as outcomes. Factors associated with decisional conflict were examined.

RELATED: PSA Screening Associated with Reduction in Prostate Cancer Death

The researchers found that poor prostate cancer knowledge correlated with elevated decisional conflict (P < 0.001) and with higher uncertainty (P = 0.001). There was also an association for poor knowledge with lower perceived effectiveness (P = 0.003). Higher decisional conflict was associated with being in a relationship (P = 0.03).

"Interventions to increase comprehension of prostate cancer and its treatments may reduce decisional conflict," the authors write. "Further work is needed to better characterize this relationship and identify effective targeted interventions."

  1. Kaplan, Alan L., MD, et al. "Decisional conflict in economically disadvantaged men with newly diagnosed prostate cancer: Baseline results from a shared decision-making trial." Cancer. DOI: 10.1002/cncr.28755. May 9, 2014.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs